Vizora日本語

Rohto PharmaceuticalROHTO PHARMACEUTICAL CO.,LTD.4527東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Which Rohto Pharmaceutical businesses make the profit?

Revenue by business segment, and the profit each one keeps.

Revenue by geography

Geographic revenue reported in annual filings

No geographic revenue breakdown was disclosed.

※ Segment figures include inter-segment sales and do not sum to the company total

Revenue and profit mix

FY ending Mar 2026

Revenue mix

Profit mix (profitable segments)

Japan accounts for 49% of revenue and 55% of profit.

  • Japan
    Revenue 49.3%Profit 54.9%Difference +5.7 ptMargin 13.1%Cosmetics
  • Asia
    Revenue 36.5%Profit 37.4%Difference +0.9 ptMargin 12.0%Cosmetics
  • Other
    Revenue 1.1%Profit 1.0%Difference -0.1 ptMargin 10.6%
  • America
    Revenue 6.3%Profit 4.2%Difference -2.0 ptMargin 7.9%Cosmetics
  • Europe
    Revenue 7.0%Profit 2.5%Difference -4.4 ptMargin 4.2%Cosmetics

Calculated from disclosed figures; listed by margin. Difference = profit share − revenue share (percentage points). Segment revenues may include inter-segment sales and may not sum to company revenue.

Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.

Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.

Segment history (JPY millions)

SegmentRevenue CAGRFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Japan+7.9%5y121,41715.8%136,66815.5%156,85115.6%164,98813.6%169,32613.1%
America+22.9%5y10,0372.2%16,6554.3%18,5656.5%20,7697.4%21,5537.9%
Europe+24.0%5y10,2975.5%12,2318.0%13,88410.0%19,1637.4%23,8894.2%
Asia+21.1%5y55,98814.9%70,77314.7%78,75115.3%100,33611.6%125,32712.0%
Other+15.5%5y1,9069.0%2,3378.7%2,7868.6%3,36610.5%3,62810.6%

Top: revenue. Bottom: operating margin.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第90期(2025/04/01－2026/03/31)

    ID S100YE5N2026-06-19Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第89期(2024/04/01－2025/03/31)

    ID S100WCHQ2025-07-11Open

  • EDINET (FSA Japan)

    有価証券報告書－第88期(2023/04/01－2024/03/31)

    ID S100TX7A2024-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第87期(2022/04/01－2023/03/31)

    ID S100R8E42023-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第86期(令和3年4月1日－令和4年3月31日)

    ID S100OFES2022-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第85期(令和2年4月1日－令和3年3月31日)

    ID S100LOGZ2021-06-25Open

Extracted from XBRL: 56 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image